Compare IBRX & VIPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | VIPS |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 7.7B |
| IPO Year | 2015 | 2012 |
| Metric | IBRX | VIPS |
|---|---|---|
| Price | $7.94 | $13.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $12.57 | ★ $19.58 |
| AVG Volume (30 Days) | ★ 10.9M | 1.8M |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $88.59 | $3.79 |
| Revenue Next Year | $131.15 | $2.05 |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $13.36 |
| 52 Week High | $12.43 | $21.08 |
| Indicator | IBRX | VIPS |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 38.97 |
| Support Level | $7.77 | N/A |
| Resistance Level | $8.51 | $18.20 |
| Average True Range (ATR) | 0.53 | 0.41 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 62.50 | 11.50 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.